Nariné Baririan joined SGS in 2007 and currently is the company’s Clinical Pharmacology Expert, and serves as part of SGS’s Clinical Pharmacology Unit (CPU) and consultancy/experts team that supports and advised clients in study design and clinical development plans of new compounds. She holds a degree in Pharmaceutical Sciences, a research master’s degree from UCL (Belgium) in Cellular and Molecular Pharmacology, as well as a doctorate in Pharmaceutical Sciences from UCL and St Luc Hospital (Brussels). She is active member of Belgian Association of Phase 1 Units (BAPU) and Association Française de Pharmacologie Translationnelle (AFPT).